Irish pharmaceuticals market major focus for Aker Kvaerner


"Ireland continues to be a major focus of investment for the pharmaceutical and biotechnology industries and, as a major global player, our Cork centre provides a principal base for future expansion in Ireland," said Mark Leggett, president of AK pharmaceuticals.
 
ENDS
 
For further information please contact:
 
Alan Cumming, Aker Kvaerner, Solent, UK. Tel: +44 (0)1489 611111
 
Jim Quigley, Aker Kvaerner, Cork, Ireland. Tel: +353 (0)21 2311700
 
AKER KVÆRNER ASA, through its subsidiaries and affiliates ("Aker Kvaerner"), is a leading global provider of engineering and construction services, technology products and integrated solutions. The business within Aker Kvaerner span a number of industries, including Oil & Gas production, Refining & Chemicals, Mining & Metals, Pharmaceuticals & Biotechnology, Power Generation and Pulp & Paper. Aker Kvaerner has aggregated annual revenues of approximately USD 4.5 billion and employs around 21,000 employees in more than 30 countries.
 
The Aker Kvaerner group consists of a number of separate legal entities. Aker Kvaerner is used as the common brand/trademark for most of these entities. The parent company in the group is Aker Kværner ASA.
 
AK pharmaceuticals
is a trading name of Aker Kvaerner Projects Ltd., the legal entity responsible for the execution of the work. AK pharmaceuticals is one of the core businesses of Aker Kvaerner in Europe. It has considerable expertise in meeting the needs of leading pharmaceutical and biotechnology companies across Europe, from first conception to implementation, validation and operation. To achieve this, we have assembled a team of leading technical specialists, many of them from within the industry itself, to bring hands-on experience to providing solutions to our customers. We work in partnership with local resources, where appropriate, to ensure that the facilities we design and build satisfy all local and federal agency requirements.
 

This press release may include forward-looking information or statements and is subject to our disclaimer, see our web-pages www.akerkvaerner.com